ClinicalTrials.Veeva

Menu
V

Vision Institute | Colorado Springs, CO

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

TP-03
RGN-259
Dexamethasone
K-161
YP-P10
OK-101
Cyclosporine
AR-15512
Restasis
TL-925

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 15 total trials

Impact of XDEMVY® on Demodex Blepharitis in Soft Contact Lens Wearers (Ariel)

To compare the efficacy of XDEMVY ophthalmic drop to its vehicle control for the treatment of Demodex blepharitis and its impact on the soft contact...

Enrolling
Demodex Blepharitis
Drug: Lotilaner ophthalmic solution, 0.25%
Drug: Vehicle control

The objective of this study is to compare the safety and efficacy of YP-P10 Ophthalmic Solution to placebo for the treatment of the signs and symptom...

Active, not recruiting
Dry Eye
Drug: 1% YP-P10 Ophthalmic Solution
Drug: 0.3% YP-P10 Ophthalmic Solution

To demonstrate the safety and effectiveness of TearCare® procedures compared to Restasis® to treat the signs and symptoms of dry eye disease in adult...

Active, not recruiting
Dry Eye
Meibomian Gland Dysfunction
Device: TearCare System
Drug: Restasis

This study will enroll subjects with stage 2 or 3 neurotrophic keratitis. Subjects will be randomized in a 1:1 ratio to the CSB-001 investigational t...

Active, not recruiting
Neurotrophic Keratitis
Biological: CSB-001 Ophthalmic Solution 0.1%
Biological: Vehicle Control

Trial sponsors

Tarsus Pharmaceuticals logo
R
Aerie Pharmaceuticals logo
Allergan logo
C
Kowa logo
Ocular Therapeutix logo
O
S
S

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems